161 related articles for article (PubMed ID: 28506076)
21. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
[TBL] [Abstract][Full Text] [Related]
22. The Chemical Biology of NO that Regulates Oncogenic Signaling and Metabolism: NOS2 and Its Role in Inflammatory Disease.
Miranda KM; Ridnour LA; Cheng RYS; Wink DA; Thomas DD
Crit Rev Oncog; 2023; 28(1):27-45. PubMed ID: 37824385
[TBL] [Abstract][Full Text] [Related]
23. S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer.
Switzer CH; Ridnour LA; Cheng R; Heinecke J; Burke A; Glynn S; Ambs S; Wink DA
For Immunopathol Dis Therap; 2012; 3(2):117-124. PubMed ID: 23543871
[TBL] [Abstract][Full Text] [Related]
24. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.
Eyler CE; Wu Q; Yan K; MacSwords JM; Chandler-Militello D; Misuraca KL; Lathia JD; Forrester MT; Lee J; Stamler JS; Goldman SA; Bredel M; McLendon RE; Sloan AE; Hjelmeland AB; Rich JN
Cell; 2011 Jul; 146(1):53-66. PubMed ID: 21729780
[TBL] [Abstract][Full Text] [Related]
25. Testosterone-induced modulation of nitric oxide-cGMP signaling pathway and androgenesis in the rat Leydig cells.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Biol Reprod; 2010 Sep; 83(3):434-42. PubMed ID: 20463352
[TBL] [Abstract][Full Text] [Related]
26. Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue.
Yang GY; Taboada S; Liao J
Methods Mol Biol; 2009; 512():119-56. PubMed ID: 19347276
[TBL] [Abstract][Full Text] [Related]
27. IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB.
Gao Q; Liu Y; Wu Y; Zhao Q; Wang L; Gao S; Wen W; Zhang W; Guo N; Zhou J; Yuan Z
Int J Mol Med; 2016 Feb; 37(2):347-58. PubMed ID: 26677135
[TBL] [Abstract][Full Text] [Related]
28. Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells.
Navarro-Lérida I; Martínez-Moreno M; Ventoso I; Alvarez-Barrientos A; Rodríguez-Crespo I
Mol Biol Cell; 2007 Jul; 18(7):2768-77. PubMed ID: 17507652
[TBL] [Abstract][Full Text] [Related]
29. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract][Full Text] [Related]
30. Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model.
Bhowmick R; Girotti AW
Cancer Lett; 2014 Feb; 343(1):115-22. PubMed ID: 24080338
[TBL] [Abstract][Full Text] [Related]
31. The nitric oxide synthase 2 pathway is targeted by both pro- and anti-inflammatory treatments in the immature human intestine.
Ferretti E; Tremblay E; Thibault MP; Grynspan D; Burghardt KM; Bettolli M; Babakissa C; Levy E; Beaulieu JF
Nitric Oxide; 2017 Jun; 66():53-61. PubMed ID: 28315470
[TBL] [Abstract][Full Text] [Related]
32. Inflammation and IGF-I activate the Akt pathway in breast cancer.
Prueitt RL; Boersma BJ; Howe TM; Goodman JE; Thomas DD; Ying L; Pfiester CM; Yfantis HG; Cottrell JR; Lee DH; Remaley AT; Hofseth LJ; Wink DA; Ambs S
Int J Cancer; 2007 Feb; 120(4):796-805. PubMed ID: 17096325
[TBL] [Abstract][Full Text] [Related]
33. Role of nitric oxide synthesized by nitric oxide synthase 2 in liver regeneration.
Kumamoto T; Togo S; Ishibe A; Morioka D; Watanabe K; Takahashi T; Shimizu T; Matsuo K; Kubota T; Tanaka K; Nagashima Y; Kawai J; Hayashizaki Y; Shimada H
Liver Int; 2008 Jul; 28(6):865-77. PubMed ID: 18384522
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthase.
Zaragozá R; Bosch A; García C; Sandoval J; Serna E; Torres L; García-Trevijano ER; Viña JR
Biochem J; 2010 May; 428(3):451-62. PubMed ID: 20345368
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of nitric oxide is a good therapeutic target for bladder tumors that express iNOS.
Belgorosky D; Langle Y; Prack Mc Cormick B; Colombo L; Sandes E; Eiján AM
Nitric Oxide; 2014 Jan; 36():11-8. PubMed ID: 24211345
[TBL] [Abstract][Full Text] [Related]
36. NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer.
Ridnour LA; Heinz WF; Cheng RY; Wink AL; Kedei N; Pore M; Imtiaz F; Femino EL; Gonzalez AL; Coutinho L; Butcher D; Edmondson EF; Rangel MC; Kinders RJ; Lipkowitz S; Wong ST; Anderson SK; McVicar DW; Li X; Glynn SA; Billiar TR; Chang JC; Hewitt SM; Ambs S; Lockett SJ; Wink DA
bioRxiv; 2023 Dec; ():. PubMed ID: 38187532
[TBL] [Abstract][Full Text] [Related]
37. Neutral sphingomyelinase inhibition decreases ER stress-mediated apoptosis and inducible nitric oxide synthase in retinal pigment epithelial cells.
Kucuksayan E; Konuk EK; Demir N; Mutus B; Aslan M
Free Radic Biol Med; 2014 Jul; 72():113-23. PubMed ID: 24742815
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide signaling in human ovarian cancer: A potential therapeutic target.
El-Sehemy A; Postovit LM; Fu Y
Nitric Oxide; 2016 Apr; 54():30-7. PubMed ID: 26891890
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
40. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
